LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

WaVe Life Sciences Ltd

Closed

7.21 6.81

Overview

Share price change

24h

Current

Min

7.19

Max

7.31

Key metrics

By Trading Economics

Income

-76M

-47M

Sales

-75M

9.2M

EPS

-0.29

Profit margin

-510.932

Employees

287

EBITDA

-75M

-50M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+185.93% upside

Dividends

By Dow Jones

Next Earnings

7 sie 2025

Market Stats

By TradingEconomics

Market Cap

-85M

963M

Previous open

0.4

Previous close

7.21

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

WaVe Life Sciences Ltd Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 paź 2024, 15:56 UTC

Acquisitions, Mergers, Takeovers

GSK Bought More Shares of Biotech Wave Life Sciences -- Barrons.com

20 cze 2024, 18:51 UTC

Earnings

Obesity-Drug Developers Look at What's Next for a $100 Billion Market -- Barrons.com

Peer Comparison

Price change

WaVe Life Sciences Ltd Forecast

Price Target

By TipRanks

185.93% upside

12 Months Forecast

Average 19.3 USD  185.93%

High 26 USD

Low 9 USD

Based on 11 Wall Street analysts offering 12 month price targets forWaVe Life Sciences Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

6.35 / 6.555Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$